Penn Capital Management Company, LLC
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1158202
PHILADELPHIA, PA
Position in AMRX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$20,446,156
+$5,578,969 QoQ
Shares Held
1,181,176
-1.2% QoQ
Ownership
0.370%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#23
of 308 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Penn Capital Management Company, LLC holds $80,501,316 across 6 Drug Manufacturers - Specialty & Generic names. AMRX ranks #2 (25.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
368,114 | $23,540,890 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
1,181,176 | $20,446,156 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
|
207,362 | $17,165,426 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
153,877 | $17,071,114 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
10,600 | $1,786,524 | |
| 6 | XERS |
Xeris Biopharma Holdings, Inc.
|
62,021 | $491,206 |
All Filings in AMRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,446,156 | 1,181,176 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $14,867,187 | 1,196,073 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $12,624,582 | 1,001,951 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||